Trinity Biotech (TRIB) EBIT Growth (5y) (2014 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -58.40% |
| Sep 30, 2024 | -31.41% |
| Jun 30, 2024 | -39.92% |
| Mar 31, 2024 | -33.90% |
| Dec 31, 2023 | -31.76% |
| Sep 30, 2023 | -41.34% |
| Jun 30, 2023 | -60.36% |
| Mar 31, 2023 | -33.05% |
| Dec 31, 2022 | -64.57% |
| Sep 30, 2022 | -48.91% |
| Jun 30, 2022 | -24.65% |
| Mar 31, 2022 | -23.98% |
| Dec 31, 2021 | -1.03% |
| Sep 30, 2021 | 0.37% |
| Jun 30, 2021 | -37.88% |
| Mar 31, 2021 | 11.02% |
| Dec 31, 2020 | 23.69% |
| Sep 30, 2020 | 25.05% |
| Jun 30, 2020 | -30.14% |
| Mar 31, 2020 | -17.14% |
| Dec 31, 2019 | -19.60% |
| Sep 30, 2019 | -22.09% |
| Jun 30, 2019 | -23.48% |
| Mar 31, 2019 | -21.77% |
| Dec 31, 2018 | -16.90% |
| Sep 30, 2018 | -23.73% |
| Jun 30, 2018 | -13.99% |
| Mar 31, 2018 | -14.23% |
| Dec 31, 2017 | -28.68% |
| Sep 30, 2017 | -18.88% |
| Jun 30, 2017 | -15.67% |
| Mar 31, 2017 | -20.55% |
| Dec 31, 2016 | -32.06% |
| Sep 30, 2016 | -7.89% |
| Jun 30, 2016 | -9.53% |
| Mar 31, 2016 | -13.18% |
| Dec 31, 2015 | -2.63% |
| Sep 30, 2015 | -1.88% |
| Jun 30, 2015 | -3.02% |
| Mar 31, 2015 | 3.35% |
| Dec 31, 2014 | 4.28% |
| Sep 30, 2014 | 4.47% |
| Jun 30, 2014 | 3.64% |
| Mar 31, 2014 | 8.17% |